Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7341852

Concept 2023-06-01 to
2024-02-29
2022-06-01 to
2023-02-28
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,105,000,000 JPY
4,106,000,000 JPY
Non-operating income
Non-operating income
106,000,000 JPY
79,000,000 JPY
Non-operating expenses
Non-operating expenses
88,000,000 JPY
107,000,000 JPY
Ordinary profit (loss)
3,122,000,000 JPY
4,077,000,000 JPY
Extraordinary income
Extraordinary income
326,000,000 JPY
JPY
Extraordinary losses
Extraordinary losses
9,000,000 JPY
81,000,000 JPY
Profit (loss) before income taxes
3,440,000,000 JPY
3,996,000,000 JPY
Profit (loss)
2,270,000,000 JPY
2,619,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.